Biomarker ID | 107 |
PMID | 16372118 |
Year | 2006 |
Biomarker | 18 proteins with Mass (Da) M3700 + M3904 + M3978 + M4300 + M5085 + M5923 + M6250 + M6569+ M6652 + M7121 + M7782 +M7850 + M7991 + M95031+ M5265 +M15878 + M16003 + M16068 |
Biomarker Basis | Expression Based |
Biomolecule | Protein |
Source | Serum |
Subjects | Humans |
Regulation | Downregulated in PCa: [M3700 + M3904 + M3978 + M4300 + M5085 + M5923 + M6250 + M6569+ M6652 + M7121 + M7782 +M7850 + M7991 + M95031Upregulated in PCa: [M5265 +M15878 + M16003 + M16068] |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | NA |
Experiment | Prostate Cancer Vs Controls |
Type of Biomarker | Diagnostic |
Cohort | Serum samples from 83 PCa patients and 95 healthy men were taken chinese patients |
Senstivity | 92% |
Specificity | 96.7% |
AUC | NA |
Accuracy | NA |
Level Of Significance | p<0.01 |
Method Used | SELDI-TOF MS |
Clinical | No |
Remarks | Names of the proteins not provided in the paper |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |